Dr. Martens plc (LON:DOCS – Get Free Report) was down 8.6% on Thursday . The stock traded as low as GBX 72.47 and last traded at GBX 74.60. Approximately 1,123,670 shares were traded during trading, a decline of 49% from the average daily volume of 2,188,012 shares. The stock had previously closed at GBX 81.60.
Analysts Set New Price Targets
Separately, Peel Hunt restated a “buy” rating on shares of Dr. Martens in a report on Thursday. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of GBX 6,000.
Read Our Latest Stock Report on DOCS
Dr. Martens Stock Performance
Dr. Martens (LON:DOCS – Get Free Report) last released its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.
Insider Buying and Selling at Dr. Martens
In other Dr. Martens news, insider Ije Nwokori sold 298,675 shares of the business’s stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total value of £268,807.50. Also, insider Giles Wilson sold 30,000 shares of the firm’s stock in a transaction dated Monday, September 1st. The stock was sold at an average price of GBX 91, for a total value of £27,300. Over the last quarter, insiders have purchased 136,960 shares of company stock valued at $12,460,163 and have sold 434,460 shares valued at $39,131,400. 2.80% of the stock is currently owned by company insiders.
Dr. Martens Company Profile
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
Featured Stories
- Five stocks we like better than Dr. Martens
- Why Are Stock Sectors Important to Successful Investing?
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- Industrial Products Stocks Investing
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- What Are Trending Stocks? Trending Stocks Explained
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
